- Home
- AJG vs GSK Comparison
AJG vs GSK Comparison
Compare AJG & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AJG
- GSK
- Stock Information
- Founded
- AJG 1927
- GSK 1715
- Country
- AJG United States
- GSK United Kingdom
- Employees
- AJG N/A
- GSK N/A
- Industry
- AJG Specialty Insurers
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- AJG Finance
- GSK Health Care
- Exchange
- AJG Nasdaq
- GSK Nasdaq
- Market Cap
- AJG 78.0B
- GSK 81.9B
- IPO Year
- AJG N/A
- GSK N/A
- Fundamental
- Price
- AJG $307.98
- GSK $43.46
- Analyst Decision
- AJG Hold
- GSK Hold
- Analyst Count
- AJG 13
- GSK 2
- Target Price
- AJG $316.00
- GSK N/A
- AVG Volume (30 Days)
- AJG 1.3M
- GSK 5.7M
- Earning Date
- AJG 10-23-2025
- GSK 10-29-2025
- Dividend Yield
- AJG 0.84%
- GSK 3.73%
- EPS Growth
- AJG 30.90
- GSK N/A
- EPS
- AJG 6.73
- GSK 1.13
- Revenue
- AJG $11,551,500,000.00
- GSK $43,336,073,439.00
- Revenue This Year
- AJG $29.56
- GSK $5.43
- Revenue Next Year
- AJG $21.66
- GSK $5.14
- P/E Ratio
- AJG $46.01
- GSK $38.30
- Revenue Growth
- AJG 11.20
- GSK 0.59
- 52 Week Low
- AJG $275.56
- GSK $31.72
- 52 Week High
- AJG $351.23
- GSK $45.59
- Technical
- Relative Strength Index (RSI)
- AJG 58.54
- GSK 63.72
- Support Level
- AJG $302.00
- GSK $43.09
- Resistance Level
- AJG $313.09
- GSK $45.59
- Average True Range (ATR)
- AJG 5.05
- GSK 0.80
- MACD
- AJG 0.70
- GSK 0.23
- Stochastic Oscillator
- AJG 70.35
- GSK 73.17
About AJG Arthur J. Gallagher & Co.
Founded in 1927 as a one-person agency, Gallagher's primary business is insurance brokerage, with a focus on serving middle-market companies. The company's risk management segment provides third-party claims adjustment to companies that choose to self-insure. Gallagher has about 56,000 employees and generates about a third of its revenue internationally, primarily in Australia, Canada, New Zealand, and the UK
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.